CD4 and AIDS: Importantly, when we reintroduced GJB2 into CD4+ T cells isolated from anti-retroviral therapy (ART)-treated patients, we observed that GJB2 overexpression still inhibited HIV-1 spread in these cells ex vivo, suggesting a potential application for combating HIV/AIDS.